Why the study?
Does intravenous amiodarone alter acute hemodynamic and electrophysiological parameters in an in vivo canine model?
Does intravenous amiodarone alter acute hemodynamic and electrophysiological parameters in an in vivo canine model?
Intravenous amiodarone demonstrates class I, III, and IV actions and shortens the electrical vulnerable period of the ventricle in a canine model, highlighting its unique antiarrhythmic properties against re-entry arrhythmias.
No takes yet. Share an insight, caveat, or question.
These canine effects leave open human translation; hypothesis-generating for amiodarone's multi-class actions in reentry.
Sugiyama et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: